Navigation Links
New Video on Plasma Donation Available
Date:1/28/2011

ANNAPOLIS, Md., Jan. 28, 2011 /PRNewswire/ -- Anyone curious about what to expect as a plasma donor and how plasma contributes to lifesaving medicines can now learn about the process thanks to a new DVD from the Plasma Protein Therapeutics Association (PPTA). "Becoming a Plasma Donor," details the safety and eligibility steps required to become a committed plasma donor at one of the 400-plus U.S. Food and Drug Administration-licensed and International Quality Plasma Program-certified plasma collection centers in the United States. The 10 minute video illustrates how critically important plasma donors are to the production of safe and effective therapies that help individuals coping with rare, chronic, life-threatening diseases.

PPTA's DVD guides viewers step-by-step through the process that a new plasma donor experiences when applying to donate plasma, from the completion and review of the health history questionnaire to the physical examination to the donation process itself.  

"I'm pleased to announce this new resource, which gives people who are interested in donating plasma important information on the plasma donation process and shows viewers what they can expect," said PPTA President and CEO Jan M. Bult.

Plasma protein therapies are used to treat life-threatening, rare, chronic diseases and disorders such as hemophilia, primary immunodeficiencies, alpha-1 antitrypsin deficiency and neurological and autoimmune disorders. In addition, plasma protein therapies are used to treat other serious medical conditions such as shock, trauma, and burns.

"A major goal of PPTA is to help promote the understanding of and access to safe and effective plasma protein therapeutics for all patients in the world," said Bult. "This DVD is an educational tool that showcases the numerous safety measures in place to protect the health of the donor and the patients who rely on therapies made from plasma."

The International Quality Plasma Program (IQPP) is a voluntary industry certification that complements the regulatory requirements of U.S. and international government authorities that govern the collection of source plasma used to manufacture therapies. The achievement of certification illustrates the industry's ongoing commitment to quality and safety.

To view the DVD online, please go to: http://www.pptaglobal.org/news/videos/plasma-donation.aspx. To obtain a copy of the new DVD, please contact Diana Krueger at dkrueger@pptaglobal.org or (443) 433-1107. For more information on the video or the plasma protein therapeutics industry, please contact Kara Flynn at (443) 458-4669 or Kym H. Kilbourne at (443) 458-4682.

The Plasma Protein Therapeutics Association (PPTA) represents the world's leading manufacturers of plasma-derived and recombinant biological therapies, collectively known as plasma protein therapies. These critical therapies are infused or injected by more than 1 million people worldwide to treat a variety of rare, life threatening diseases and serious medical conditions. PPTA members produce in excess of 80 percent of the plasma protein therapies used in the United States today and more than 60 percent worldwide. The manufacturer membership of PPTA in the United States currently includes Baxter, Biotest, Cangene, CSL Behring, Grifols, and Talecris. PPTA is a global trade association that administers international, voluntary standards programs to help ensure the highest quality and safety of plasma protein therapies and the plasma collected to manufacture them. Additionally, PPTA works in partnership with the patient community and consumer advocates to help ensure continued access to lifesaving plasma protein therapies.


'/>"/>
SOURCE Plasma Protein Therapeutics Association (PPTA)
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
2. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
3. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
4. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
5. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
6. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
7. Video: Keppra XR(TM) Approved in the U.S.
8. Video: Fortune 1000 Executives: New President Must Fix Education Gap
9. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
10. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
11. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... ... August 09, 2017 , ... SPIE, the ... laboratories — the Wellman Center for Photomedicine, the Manstein Lab in the Cutaneous ... Beckman Laser Institute at University of California, Irvine — and the Hillenkamp family ...
(Date:8/10/2017)... (PRWEB) , ... August 10, 2017 , ... ... the stock market news outlet had initiated coverage on Next Group Holdings, Inc. ... and underserved consumer markets geared toward those that cannot engage in traditional banking ...
(Date:8/8/2017)... ... August 08, 2017 , ... HumanZyme ... in human cells, today announced the launch of HumanKine® Interferon beta ... I family of interferons that activate Th1-type innate immune responses against viral and bacterial ...
(Date:8/8/2017)... ... 08, 2017 , ... Myoderm , a global clinical trial drug supply ... announcement comes on the heels of the opening of Myoderm’s European warehouse facility earlier ... to adding staff and establishing operations to support its customers around the world. ...
Breaking Biology Technology:
(Date:7/20/2017)... (NYSE: DAL ) customers now can use fingerprints instead of ... Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in May ... boarding process to allow eligible Delta SkyMiles Members who are enrolled in ...
(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
(Date:5/23/2017)... 2017  Hunova, the first robotic gym for the rehabilitation and functional ... in Genoa, Italy . The first 30 robots will ... USA . The technology was developed and patented at ... IIT spin-off Movendo Technology thanks to a 10 million euro investment from ... click: ...
Breaking Biology News(10 mins):